DR ABSAR KHALID MIR; DR MOHAMMAD AHMAD ABBASI; DR LAIBA MUSTANSAR SAHI; DR SAMANA BATOOL; DR MUHAMMAD BILAL ANWAR; DR TEHREEM ALI; DR ABEERA KAZMI; DR ISRAA ALAM; DR MUHAMMAD ALI HASSAN. EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 6, p. 1059–1065, 2024. DOI: 10.53555/jptcp.v31i6.6611. Disponível em: https://mail.jptcp.com/index.php/jptcp/article/view/6611. Acesso em: 21 dec. 2024.